Skip to main content
. 2018 Mar 30;97(13):e0245. doi: 10.1097/MD.0000000000010245

Figure 1.

Figure 1

Twelve month survival in patients treated with AMB-D, or AMB-L compared to AMB-LC. The mean survival time (standard error) during the 1 year of followup was 10.6 months (0.5 months) in patients treated with AMB-D, or AMB-L, and 8.3 months (1.1 months) in patients treated with amphotericin B lipid complex, P = .040. Data are calculated as the restricted mean with an upper limit of 12 months. This is the expected number of months, out of the first 12, that would be experienced by each group. AMB-D = deoxycholate amphotericin B, AMB-L = liposomal amphotericin B, AMB-LC = lipid complex amphotericin B.